ARTICLE SUMMARY:
With US and European medical device markets still sputtering toward recovery, multinational device manufacturers have been intensifying their push into higher-growth emerging markets, with China remaining a leading target. But what does it take to be successful in China? Although the growth fundamentals and expansive potential opportunities in China are real, the country presents some critical challenges for companies attempting to navigate its complicated, and sometimes risky, healthcare system.
Multinational medical device manufacturers continue to expand their footprints in emerging markets, tapping into promising underserved opportunities not only in the widely recognized BRIC nations (Brazil, Russia, India, and China), but also branching well beyond into areas such as the Middle East, Africa, Latin America and Mexico, and Southeast Asia.
